Anebulo Pharmaceuticals Plans to Go Private, Triggering Stock Surge
Anebulo Pharmaceuticals, a clinical-stage biotech company, has announced plans to go private, leading to a surge in its stock price and a potential restructuring of its financial standing.
2 minutes to read